161 related articles for article (PubMed ID: 25890845)
1. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
[TBL] [Abstract][Full Text] [Related]
2. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
Jarosek SL; Virnig BA; Chu H; Elliott SP
Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
[TBL] [Abstract][Full Text] [Related]
3. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy.
Tward JD; Jarosek S; Chu H; Thorpe C; Shrieve DC; Elliott S
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1443-1453. PubMed ID: 27325475
[TBL] [Abstract][Full Text] [Related]
4. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
[TBL] [Abstract][Full Text] [Related]
5. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
[TBL] [Abstract][Full Text] [Related]
6. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
Kwaan MR; Fan Y; Jarosek S; Elliott SP
Dis Colon Rectum; 2017 Jul; 60(7):682-690. PubMed ID: 28594717
[TBL] [Abstract][Full Text] [Related]
7. Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer.
Mayer EN; Tward JD; Bassett M; Lenherr SM; Hotaling JM; Brant WO; Lowrance WT; Myers JB
BJU Int; 2017 May; 119(5):700-708. PubMed ID: 27469289
[TBL] [Abstract][Full Text] [Related]
8. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women.
Fujikawa K; Miyamoto T; Ihara Y; Matsui Y; Takeuchi H
Gynecol Oncol; 2001 Jan; 80(1):21-3. PubMed ID: 11136564
[TBL] [Abstract][Full Text] [Related]
9. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
12. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
Stokes WA; Jones BL; Schefter TE; Fisher CM
Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
[TBL] [Abstract][Full Text] [Related]
13. Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.
Xiang M; Nguyen PL
Brachytherapy; 2015; 14(6):773-80. PubMed ID: 26489921
[TBL] [Abstract][Full Text] [Related]
14. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
[TBL] [Abstract][Full Text] [Related]
15. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
16. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
17. A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.
Welk B; Wallis C; D'Souza D; McGee J; Nam RK
Int J Gynecol Cancer; 2018 Jun; 28(5):989-995. PubMed ID: 29664839
[TBL] [Abstract][Full Text] [Related]
18. Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy.
Sewell JM; Rao A; Elliott SP
Urology; 2013 Aug; 82(2):335-40. PubMed ID: 23746713
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer.
Yin M; Zhao J; Monk P; Martin D; Folefac E; Joshi M; Jin N; Mortazavi A; Verschraegen C; Clinton S
Cancer Med; 2020 Jan; 9(1):27-34. PubMed ID: 31697452
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
